Hugo R Lara-Martinez: Acute Immune Thrombocytopenia Following First Obinutuzumab Exposure
Hugo R Lara-Martinez, Former Assistant Professor of Medicine-Hematology at MD Anderson Cancer Center, shared a post on LinkedIn about a recent article he and Judy Al-Sayyad co-authored, published in Blood Vessels, Thrombosis and Hemostasis, adding:
“Excited to share our recently published case report, ‘Immune-Mediated Acute Thrombocytopenia Within 30 Minutes of First Obinutuzumab Infusion,’ in Blood Vessels, Thrombosis and Hemostasis.
We describe a rare but potentially serious complication of obinutuzumab, with profound thrombocytopenia developing shortly after the first infusion.
This case highlights the importance of recognizing obinutuzumab-induced acute thrombocytopenia and distinguishing it from other causes of thrombocytopenia in patients receiving anti-CD20 therapy.
A great collaboration with Judy Al-Sayyad and an important clinical reminder that sometimes the timing of an adverse event provides the biggest clue to the diagnosis.”
Title: Immune-mediated acute thrombocytopenia within 30 minutes of first obinutuzumab infusion
Authors: Judy Al-Sayyad, Hugo R Lara-Martinez
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 7, 2026, 15:00Haroon Gul Khan: Why Critical Reading Matters in Medical Education
-
Sep 7, 2026, 14:59Ahmed Mahmoud: Vitamin B12 Deficiency Can Present Far Beyond Fatigue and Macrocytic Anemia
-
Sep 7, 2026, 14:49Abid Husain: Tirzepatide Drives Broad Improvements in Cardiovascular Risk Biomarkers
-
Sep 7, 2026, 14:46Shabnam Arsiwala: Did You Know there are Multiple Types of Sickle Cell Disease?
-
Sep 7, 2026, 14:46Ahmed Bennis: Angiotensin II and Platelet PAR4 Activation in Hypertension
-
Sep 7, 2026, 14:42Scott Isaacs: Obesity Is Not Only a Cardiometabolic Disease
-
Sep 7, 2026, 14:41Chayakrit Krittanawong: Precision Anticoagulation in the Cath Lab – What Happens when the Patient Doesn’t Look like the Trial?
-
Sep 7, 2026, 14:29Andrei Mesina: Tailoring Post-PCI Antithrombotic Therapy Balances Bleeding and Ischaemic Risks
-
Sep 7, 2026, 14:27Davide Capodanno: Lp(a) After HORIZON and the Outcome Question